Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
15 December 2022Website:
http://www.gehealthcare.comNext earnings report:
25 July 2024Last dividends:
18 April 2024Next dividends:
19 July 2024Price
after hours | Wed, 03 Jul 2024 20:45:56 GMTAnalysts recommendations
Institutional Ownership
GEHC Latest News
GE Healthcare Technologies, Inc. GEHC, in collaboration with the University of Cincinnati (UC), UC Health, and Cincinnati Children's, has announced a cutting-edge initiative to accelerate MRI innovation. This collaboration will provide a well-established MRI Research and Development (R&D) center of excellence on UC's medical campus, enabling direct interaction between clinical investigators and GE HealthCare scientists.
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per share of Common Stock for the second quarter of 2024 payable on August 15, 2024 to all shareholders of record as of July 19, 2024. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytic.
GE HealthCare's (GEHC) latest collaboration is likely to enable clinicians to perform complex cardiology interventions with a high level of precision and improved image quality.
GE HealthCare's (GEHC) latest successful first installation and clinical cases using the OmnifyXR are likely to improve clinical and operational outcomes for both patients and clinicians.
CHICAGO--(BUSINESS WIRE)--GE HealthCare, MediView XR, Inc. announce first installation, clinical use of OmnifyXR Interventional Suite at North Star Vascular & Interventional.
With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.
GE HealthCare's (GEHC) latest agreement is likely to standardize care protocols and improve the quality of CT, MR and ultrasound examinations.
Despite being unwanted and unloved, spinoff stocks are often excellent stocks to buy and hold. Since investors bought shares in the parent company, they are often not interested in the business.
GE Healthcare (GEHC) and Medis Medical are working together to improve precision care for treating coronary artery disease.
The company is expected to continue growing in 2024 according to management, who believes that introducing new products will help drive growth and increase margins.
What type of business is GE HealthCare Technologies?
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
What sector is GE HealthCare Technologies in?
GE HealthCare Technologies is in the Healthcare sector
What industry is GE HealthCare Technologies in?
GE HealthCare Technologies is in the Health Information Services industry
What country is GE HealthCare Technologies from?
GE HealthCare Technologies is headquartered in United States
When did GE HealthCare Technologies go public?
GE HealthCare Technologies initial public offering (IPO) was on 15 December 2022
What is GE HealthCare Technologies website?
https://www.gehealthcare.com
Is GE HealthCare Technologies in the S&P 500?
Yes, GE HealthCare Technologies is included in the S&P 500 index
Is GE HealthCare Technologies in the NASDAQ 100?
Yes, GE HealthCare Technologies is included in the NASDAQ 100 index
Is GE HealthCare Technologies in the Dow Jones?
No, GE HealthCare Technologies is not included in the Dow Jones index
When does GE HealthCare Technologies report earnings?
The next expected earnings date for GE HealthCare Technologies is 25 July 2024